Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentOpen to AccrualParticipants Off Study and Primary Analysis CompletedPendingTemporarily Closed (Paused) to Accrual and Study Agents/ProductsWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 117 studies. P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded P1085: Human Papilloma Virus (HPV) Type-Specific Antibody DAIDS Number 10826 Research Area Other Study Status Concluded P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up P1083: Kaletra/Aluvia PK study DAIDS Number 10787 Research Area Treatment Study Status Concluded P1081: 3 Regimens for HIV Infected Women initiating ARV regimens for PMTCT DAIDS Number 10770 Research Area Mother to child transmission Study Status Temporarily Closed (Paused) to Accrual and Study Agents/Products P1080: ARV & Psychiatric Medication Concentrations in HIV Infected & Uninfected Children DAIDS Number 10768 Research Area Complications & Comorbidities Study Status Closed to Follow Up P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis 1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed Pagination Previous page Prev Page 1 … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Page 12 Next page Next
P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded
P1085: Human Papilloma Virus (HPV) Type-Specific Antibody DAIDS Number 10826 Research Area Other Study Status Concluded
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up
P1081: 3 Regimens for HIV Infected Women initiating ARV regimens for PMTCT DAIDS Number 10770 Research Area Mother to child transmission Study Status Temporarily Closed (Paused) to Accrual and Study Agents/Products
P1080: ARV & Psychiatric Medication Concentrations in HIV Infected & Uninfected Children DAIDS Number 10768 Research Area Complications & Comorbidities Study Status Closed to Follow Up
P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis
1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
